Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space

av Sartor, A Oliver
Publicerad 2011

Germline BLM mutations and metastatic prostate cancer

av Ledet, Elisa M., Antonarakis, Emmanuel S., Isaacs, William B., Lotan, Tamara L., Pritchard, Colin, Sartor, A. Oliver
I publikationen Prostate (2019)

A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches

av Chabner, Bruce A., Bates, Susan E., Fojo, Antonio Tito, Murphy, Ann, Sartor, A. Oliver, Murphy, Martin J.
I publikationen Oncologist (2021)

Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease

av Bennett, Charles L., Qureshi, Zaina P., Sartor, A. Oliver, Norris, LeAnn B., Murday, Alanna, Xirasagar, Sudha, Thomsen, Henrik S.
Publicerad 2012

Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer

av Moses, Marcus, Koksal, Ulkuhan, Ledet, Elisa, Manogue, Charlotte, Cotogno, Patrick, Lewis, Brian, Layton, Jodi, Sartor, A. Oliver, Barata, Pedro
I publikationen Oncotarget (2020)

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

av Armstrong, Andrew J., Eisenberger, Mario A., Halabi, Susan, Oudard, Stephane, Nanus, David M., Petrylak, Daniel P., Sartor, A. Oliver, Scher, Howard I.
Publicerad 2011

Cytokine genetic polymorphisms and prostate cancer aggressiveness

av Zabaleta, Jovanny, Su, L. Joseph, Lin, Hui-Yi, Sierra, Rosa A., Hall, M. Craig, Sartor, A. Oliver, Clark, Peter E., Hu, Jennifer J., Ochoa, Augusto C.
Publicerad 2009

Antiandrogen Withdrawal in Castrate-refractory Prostate Cancer: A Southwest Oncology Group Trial (SWOG 9426)

av Sartor, A. Oliver, Tangen, Catherine M., Hussain, Maha H. A., Eisenberger, Mario A., Parab, Minoti, Fontana, Joseph A., Chapman, Robert A., Mills, Glenn M., Raghavan, Derek, Crawford, E. David
Publicerad 2008

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer

av Beer, Tomasz M, Vogelzang, Nicholas, Bartůňková, Jiřina, Miller, Kurt, Oh, William, Oudard, Stephane, Pandha, Hardev, Sartor, A Oliver, Špíšek, Radek, Toole, Timothy O, Borgstein, Niels G, Gerritsen, Winald R
I publikationen J Immunother Cancer (2015)

CD4(+) T helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion

av Liu, Sen, Liu, Fengli, Zhang, Bing, Yan, Peng, Rowan, Brian G., Abdel-Mageed, Asim B., Steele, Chad, Jazwinski, S. Michal, Moroz, Krzysztof, Norton, Elizabeth B., Wang, Alun, Myers, Leann, Sartor, A. Oliver, Zhang, Qiuyang
I publikationen Prostate (2020)

Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes: A Meta-analysis of Individual Patient Data From Ra...

av Terrisse, Safae, Karamouza, Eleni, Parker, Chris C., Sartor, A. Oliver, James, Nicholas D., Pirrie, Sarah, Collette, Laurence, Tombal, Bertrand F., Chahoud, Jad, Smeland, Sigbjørn, Erikstein, Bjørn, Pignon, Jean-Pierre, Fizazi, Karim, Le Teuff, Gwénaël
I publikationen JAMA Oncol (2020)

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer

av Pomerantz, Mark M., Spisák, Sandor, Jia, Li, Cronin, Angel M., Csabai, Istvan, Ledet, Elisa, Sartor, A. Oliver, Rainville, Irene, O’Connor, Edward, Herbert, Zachary T., Szállási, Zoltan, Oh, William K., Kantoff, Philip W., Garber, Judy E., Schrag, Deborah, Kibel, Adam S., Freedman, Matthew L.
I publikationen Cancer (2017)

A Phase III trial of 2 Years of Androgen Suppression (AS) and Radiation Therapy (RT) with or without Adjuvant Chemotherapy (CT) for High-Risk Prostate Cancer: Final Results of Radi...

av Rosenthal, Seth A., Hunt, Daniel, Sartor, A. Oliver, Pienta, Kenneth J., Gomella, Leonard, Grignon, David, Rajan, Raghu, Kerlin, Kevin J., Jones, Christopher U., Dobelbower, Michael, Shipley, William U., Zeitzer, Kenneth, Hamstra, Daniel A., Donavanik, Viroon, Rotman, Marvin, Hartford, Alan C., Michalski, Jeffrey, Seider, Michael, Kim, Harold, Kuban, Deborah A., Moughan, Jennifer, Sandler, Howard
I publikationen Int J Radiat Oncol Biol Phys (2015)

Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study

av Smith, Matthew R., Sweeney, Christopher J., Corn, Paul G., Rathkopf, Dana E., Smith, David C., Hussain, Maha, George, Daniel J., Higano, Celestia S., Harzstark, Andrea L., Sartor, A. Oliver, Vogelzang, Nicholas J., Gordon, Michael S., de Bono, Johann S., Haas, Naomi B., Logothetis, Christopher J., Elfiky, Aymen, Scheffold, Christian, Laird, A. Douglas, Schimmoller, Frauke, Basch, Ethan M., Scher, Howard I.
I publikationen J Clin Oncol (2014)

Real‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancer

av Higano, Celestia S., Armstrong, Andrew J., Sartor, A. Oliver, Vogelzang, Nicholas J., Kantoff, Philip W., McLeod, David G., Pieczonka, Christopher M., Penson, David F., Shore, Neal D., Vacirca, Jeffrey, Concepcion, Raoul S., Tutrone, Ronald F., Nordquist, Luke T., Quinn, David I., Kassabian, Vahan, Scholz, Mark C., Harmon, Matt, Tyler, Robert C., Chang, Nancy N., Tang, Hong, Cooperberg, Matthew R.
I publikationen Cancer (2019)